CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended
	May 31, 2014	May 31, 2013
Cash flow from operating activities:
Net loss for the period	$ (3,048,284)	$ (2,883,143)
Adjustments to reconcile net loss to net cash provided by (used in) operations
Depreciation and amortization	222,197	243,695
Stock-based compensation	95,749	66,633
Unrealized foreign exchange gain	(40,357)	(76,193)
Deferred financing fees amortization	42,715	22,583
Accrued interest	90,623	81,641
Bad debts	35,662	0
Issuance of common stock/units for consulting services	371,854	0
Changes in operating assets and liabilities:
Accounts receivable	982,617	(113,432)
Inventories	551,335	97,173
Prepaid expenses and deposits	(240,184)	(15,756)
Accounts payable and accrued liabilities	(1,012,596)	440,132
Customer deposits	919	0
Net cash used in operating activities	(1,947,750)	(2,136,667)
Cash flows from investing activities:
Additions to property, plant and equipment	(90,027)	(351,828)
Additions to intangible assets	0	(191)
Net cash used in investing activities	(90,027)	(352,019)
Cash flows from financing activities:
Repayment of credit facility	(1,019,513)	0
Advances from short-term loans	135,705	385,800
Repayments of short term loans	(269,401)	0
Advances from related parties and others	172,000	519,258
Repayments to related parties and others	(33,835)	0
Issuance of common stock/units under private placement (net of issuance costs)	6,812,963	1,369,390
Issuance of common stock/units for cash	100,000	0
Issuance of common stock upon conversion of placement agent warrants	14,000	0
Net cash provided by financing activities	5,911,919	2,274,448
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	3,874,142	(214,238)
Cash and cash equivalents, beginning of period	174,084	402,724
CASH AND CASH EQUIVALENTS, END OF PERIOD	4,048,226	188,486
Supplemental disclosures of cash flow information, cash paid:
Interest paid	216,674	171,723
Common shares issued as repayment of loan	$ 128,000	$ 0